Cooper Cos. (COO) Reports In-Line Q3 EPS, Boosts FY14 Guidance
Cooper Cos. (NYSE: COO) reported Q3 EPS of $1.90, in-line with the analyst estimate of $1.90. Revenue for the quarter came in at $432.5 million versus the consensus estimate of $443.7 million.
Cooper Cos. sees Q4 2014 EPS of $2.00-$2.10, versus the consensus of $1.82. Cooper Cos. sees Q4 2014 revenue of $477-490 million, versus the consensus of $494.24 million.
Cooper Cos. sees FY2014 EPS of $6.80-$7.00, versus the consensus of $6.84. Cooper Cos. sees FY2014 revenue of $1.69-1.73 billion, versus the consensus of $1.75 billion.
Commenting on the results, Robert S. Weiss, Cooper's president and chief executive officer said, "We are very proud of our achievements since last quarter. We continued executing on our long-term strategic objectives including announcing and closing the acquisition of Sauflon Pharmaceuticals, a European manufacturer and distributor of soft contact lenses and solutions. We believe this acquisition positions us at the forefront of the single-use market, the fastest growing segment of the soft contact lens industry. Our businesses continue to perform well and we remain excited about the future."
For earnings history and earnings-related data on Cooper Cos. (COO) click here.